Aesthetic Medical International Holdings Group Limited (PAIYY) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Aesthetic Medical International Holdings Group Limited (PAIYY) trades at $0.021 with AI Score 51/100 (Grade B). Aesthetic Medical International Holdings Group Limited offers surgical, non-surgical, and general healthcare services across China and Singapore. Sector: Healthcare.
Price as of Jul 24, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for PAIYY: PAIYY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PAIYY against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
PAIYY: 1/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Aesthetic Medical International Holdings Group Limited (PAIYY) Healthcare & Pipeline Overview
Aesthetic Medical International Holdings Group Limited operates in the specialized aesthetic medical services sector across China and Singapore, providing a comprehensive range of surgical and non-surgical treatments alongside general healthcare services. The company, established in 1997, positions itself in a growing market for cosmetic and wellness procedures, leveraging its dual-market presence to address diverse consumer demands.
What Is the Investment Thesis for PAIYY?
Aesthetic Medical International Holdings Group Limited operates in the growing aesthetic medical and general healthcare markets of China and Singapore. The company's comprehensive service portfolio, spanning surgical enhancements like breast augmentation and non-surgical options such as laser treatments, positions it to capture demand across various consumer segments. While the company reported a negative profit margin of -7.4%, its gross margin of 46.2% indicates strong operational efficiency in service delivery before overheads. Future growth could be driven by increasing disposable incomes in its target markets and rising consumer acceptance of aesthetic procedures. The company's dual focus on aesthetic and general healthcare services provides a diversified revenue stream. However, its current market capitalization of $0.00B and status as an OTC-traded ADR suggest inherent liquidity and valuation challenges. Monitoring improvements in profitability and market penetration in key service lines will be crucial for assessing its long-term value proposition.
Based on FMP financials and quantitative analysis
PAIYY Key Highlights
- Gross Margin: 46.2%, indicating strong profitability at the service delivery level.
- Profit Margin: -7.4%, reflecting a current net loss despite robust gross margins.
- Market Capitalization: $0.00B, signifying a very small market valuation or potential data discrepancy.
- Employee Base: 1286 employees, supporting a broad range of medical and aesthetic services.
- Geographic Reach: Operations across the People's Republic of China and Singapore, targeting key Asian markets.
Who Are PAIYY's Competitors?
What Are PAIYY's Key Strengths?
- Broad portfolio of surgical, non-surgical aesthetic, and general healthcare services.
- Established presence in two key Asian markets: China and Singapore.
- Long operational history since 1997, suggesting experience and market adaptation.
- Strong gross margin of 46.2% on services rendered.
What Are PAIYY's Weaknesses?
- Negative profit margin of -7.4%, indicating unprofitability at the net level.
- Market capitalization of $0.00B, suggesting a very small valuation or data anomaly.
- Trades on the OTC market, which typically implies lower liquidity and less stringent reporting.
- Beta of -0.46, indicating unusual price movement relative to the broader market, potentially due to low trading volume or specific company factors.
What Could Drive PAIYY Stock Higher?
- Potential for improved profitability metrics as the company refines its operational efficiency and cost structure, moving from a -7.4% profit margin towards positive territory.
- Continued expansion of the aesthetic medical market in China and Singapore, driven by increasing consumer disposable income and demand for elective procedures.
- Introduction of new, advanced non-surgical aesthetic technologies or treatments that could attract a broader client base and enhance service differentiation.
- Strategic initiatives to enhance brand recognition and patient trust across its dual-market operations, potentially leading to increased client acquisition and retention.
What Are the Key Risks for PAIYY?
- Persistent negative profit margin of -7.4%, indicating challenges in achieving overall profitability despite a strong gross margin.
- Intense competition within the aesthetic medical sector in China and Singapore, potentially leading to pricing pressures and reduced market share.
- Regulatory changes or increased scrutiny in the aesthetic and general healthcare industries in its operating regions, which could impact operational costs or service offerings.
- Economic slowdowns in China or Singapore, which could reduce consumer discretionary spending on elective aesthetic procedures.
- The inherent risks associated with trading on the OTC Other market, including limited liquidity, unknown disclosure status, and potential price volatility.
What Are the Growth Opportunities for PAIYY?
- Expansion in Non-Surgical Aesthetic Treatments: The global market for non-surgical aesthetic procedures is projected to grow significantly, driven by consumer preference for less invasive options with minimal downtime. Aesthetic Medical International Holdings Group Limited's focus on minimally invasive and energy-based treatments, such as laser, ultrasound, and radiofrequency therapies, positions it well to capitalize on this trend. Expanding the range of these services and investing in the latest technologies could attract a broader client base, particularly younger demographics and those seeking subtle enhancements. This segment often has higher repeat business potential and can contribute to more stable revenue streams, with market estimates suggesting continued strong growth through the next decade.
- Geographic Penetration in Tier-2 and Tier-3 Chinese Cities: While the company operates in major markets like Shenzhen, there is substantial untapped potential in China's rapidly developing tier-2 and tier-3 cities. These regions are experiencing significant economic growth and increasing consumer demand for aesthetic services, often with less saturated competition compared to tier-1 cities. Strategic expansion into these areas, potentially through partnerships or new clinic openings, could unlock substantial market share. This growth strategy would involve adapting service offerings to local preferences and pricing sensitivities, targeting a timeline of 3-5 years for establishing a meaningful presence and capturing a share of this expanding market.
- Integration of Advanced Digital Health Platforms: The adoption of digital health technologies, including telemedicine, online consultations, and AI-powered diagnostic tools, presents a significant growth avenue. Aesthetic Medical International Holdings Group Limited could enhance its customer engagement and operational efficiency by integrating advanced digital platforms for appointment booking, post-treatment follow-ups, and personalized treatment plans. This would not only improve patient experience but also extend reach beyond physical clinics, particularly for initial consultations or general healthcare services. The market for digital health solutions is rapidly expanding, offering opportunities for improved patient access and data-driven service optimization within the next 2-3 years.
- Diversification into Wellness and Anti-Aging Services: The aesthetic medical market is increasingly converging with the broader wellness and anti-aging sectors. Expanding services to include holistic wellness programs, nutritional counseling, hormone therapy, and advanced anti-aging treatments could attract a new segment of health-conscious consumers. This diversification would leverage the company's existing medical infrastructure and expertise, allowing it to tap into a larger market that values preventative health and longevity. The global anti-aging market is substantial and growing, providing a long-term opportunity for PAIYY to broaden its appeal and create recurring revenue streams over the next 5-7 years.
- Strategic Partnerships and Acquisitions: Pursuing strategic partnerships with medical device manufacturers, pharmaceutical companies, or complementary service providers could enhance Aesthetic Medical International Holdings Group Limited's market position and service capabilities. Acquisitions of smaller, specialized clinics or technology startups could also accelerate market entry into new service lines or geographies. This inorganic growth strategy could provide access to new patient bases, specialized expertise, and proprietary technologies, strengthening the company's competitive advantage. Such opportunities could materialize over a 1-3 year horizon, depending on market conditions and available targets.
What Opportunities Does PAIYY Have?
- Growing demand for aesthetic medical services in China and Southeast Asia.
- Expansion into new geographic regions or underserved urban areas within existing markets.
- Introduction of new, advanced non-surgical aesthetic technologies and treatments.
- Strategic partnerships or acquisitions to expand service offerings or market reach.
What Threats Does PAIYY Face?
- Intense competition from both domestic and international aesthetic clinics and hospitals.
- Regulatory changes or increased scrutiny in the aesthetic medical sector in China or Singapore.
- Economic downturns impacting consumer discretionary spending on aesthetic procedures.
- Reputational risks associated with medical procedures and patient outcomes.
What Are PAIYY's Competitive Advantages?
- Diversified Service Portfolio: Offering both surgical and non-surgical aesthetic treatments alongside general healthcare services creates a broader appeal and potential for cross-selling, differentiating it from specialized clinics.
- Established Geographic Presence: Operating in both China and Singapore provides a dual-market advantage, leveraging different regulatory environments and consumer demographics.
- Brand Reputation and Trust: Over two decades of operation since 1997 may have fostered a degree of brand recognition and patient trust in its target markets.
- Integrated Medical Expertise: The ability to provide a wide range of medical services, from aesthetic to general healthcare, suggests a comprehensive medical infrastructure and skilled professional staff.
What Does PAIYY Do?
Aesthetic Medical International Holdings Group Limited, founded in 1997 and headquartered in Shenzhen, China, has evolved into a significant provider of aesthetic medical services across the People's Republic of China and Singapore. The company's operational scope encompasses a broad spectrum of treatments designed to meet diverse consumer needs in the rapidly expanding aesthetic market. Its core offerings are bifurcated into surgical and non-surgical aesthetic treatments. Surgical procedures include complex interventions such as eye surgery, rhinoplasty, breast augmentation, and liposuction, catering to clients seeking transformative cosmetic enhancements. Complementing these are non-surgical aesthetic treatments, which leverage advanced technologies like minimally invasive techniques and energy-based therapies, including laser, ultrasound, and radiofrequency treatments. This diversified approach allows the company to address a wide demographic, from those seeking significant changes to individuals preferring less invasive cosmetic improvements. Beyond aesthetic services, Aesthetic Medical International Holdings Group Limited also extends its offerings to general healthcare and other specialized medical services. This includes internal medicine, urology, gynecology, and obstetrics treatment services, demonstrating a broader commitment to patient well-being. Furthermore, the company provides dentistry, dermatology, and hair loss treatment services, integrating various medical disciplines under its umbrella. With 1286 employees, the company maintains a substantial operational footprint, aiming to capture market share in both the high-demand aesthetic sector and essential general healthcare services within its geographic regions. Its long-standing presence since 1997 underscores its experience and adaptation within the dynamic healthcare landscape.
What Products and Services Does PAIYY Offer?
- Provides surgical aesthetic treatments like eye surgery, rhinoplasty, breast augmentation, and liposuction.
- Offers non-surgical aesthetic treatments, including minimally invasive and energy-based therapies (laser, ultrasound, radiofrequency).
- Delivers general healthcare services such as internal medicine, urology, gynecology, and obstetrics.
- Specializes in dentistry services.
- Provides dermatology treatments for various skin conditions.
- Offers hair loss treatment services.
- Operates medical facilities in the People's Republic of China.
- Maintains a presence in Singapore for aesthetic medical services.
How Does PAIYY Make Money?
- Generates revenue primarily from fees charged for surgical and non-surgical aesthetic medical procedures.
- Earns income from providing general healthcare services, including consultations and treatments in various medical specialties.
- Monetizes specialized services such as dentistry, dermatology, and hair loss treatments.
- Operates through a network of clinics and medical facilities in its target markets.
- Focuses on a direct-to-consumer model, attracting clients seeking elective medical and aesthetic services.
What Industry Does PAIYY Operate In?
Aesthetic Medical International Holdings Group Limited is positioned within the dynamic and expanding Medical - Equipment & Services industry, specifically focusing on aesthetic medicine and general healthcare in China and Singapore. The global aesthetic medicine market is experiencing significant growth, driven by increasing disposable incomes, rising beauty consciousness, and advancements in medical technologies. In China, the market for aesthetic procedures is particularly robust, characterized by a growing middle class and evolving cultural perceptions towards cosmetic enhancements. The company's diversified service offering, encompassing both surgical and non-surgical treatments, allows it to cater to a broad spectrum of consumer preferences. Its presence in Singapore further expands its market reach within a region known for its advanced healthcare infrastructure and affluent consumer base. The competitive landscape includes both large hospital groups and specialized clinics, with differentiation often stemming from brand reputation, service quality, and technological adoption. PAIYY's strategy of combining aesthetic services with general healthcare aims to create a more comprehensive patient offering and potentially enhance customer loyalty.
Who Are PAIYY's Key Customers?
- Individuals seeking cosmetic enhancements through surgical procedures (e.g., breast augmentation, rhinoplasty).
- Consumers interested in non-surgical aesthetic treatments for skin rejuvenation, body contouring, and anti-aging.
- Patients requiring general medical services, including internal medicine, gynecology, and obstetrics.
- Clients seeking specialized dental, dermatological, or hair loss treatments.
- Middle to high-income individuals in China and Singapore with disposable income for elective medical services.
Company Profile
Aesthetic Medical International Holdings Group Limited operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Shenzhen, CN. The company is led by CEO Laurent Favre. PAIYY has traded publicly since 2019.
Key Financial Metrics
Return on assets is -10.2%, showing how much profit it generates from its asset base. A current ratio of 0.31 means current liabilities exceed short-term assets, a liquidity point worth watching.
FY2026 estForward Outlook
Wall Street analysts project Aesthetic Medical International Holdings Group Limited revenue of about $950.1M for fiscal 2026, with EPS near $4.04.
PAIYY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Broad portfolio of surgical, non-surgical aesthetic, and general healthcare services.
- Established presence in two key Asian markets: China and Singapore.
- Long operational history since 1997, suggesting experience and market adaptation.
- Strong gross margin of 46.2% on services rendered.
Bear Case
- Negative profit margin of -7.4%, indicating unprofitability at the net level.
- Market capitalization of $0.00B, suggesting a very small valuation or data anomaly.
- Trades on the OTC market, which typically implies lower liquidity and less stringent reporting.
- Beta of -0.46, indicating unusual price movement relative to the broader market, potentially due to low trading volume or specific company factors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
PAIYY Latest News
No recent news available for PAIYY.
PAIYY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PAIYY.
Price Targets
Wall Street price target analysis for PAIYY.
PAIYY MoonshotScore
What does this score mean?
The MoonshotScore rates PAIYY 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Chen Zhang
Chief Executive Officer
Chen Zhang serves as the leader of Aesthetic Medical International Holdings Group Limited, overseeing a workforce of 1286 employees. While specific details regarding his educational background and prior career history are not provided in the available data, his role as the head of an organization with a significant employee base in the specialized healthcare sector suggests extensive experience in operational management and strategic leadership within the medical or related industries. His tenure involves guiding a company that has been operational since 1997, navigating the complexities of aesthetic medicine and general healthcare across two distinct Asian markets.
Track Record: Under Chen Zhang's leadership, Aesthetic Medical International Holdings Group Limited has maintained its operational footprint across China and Singapore, continuing to provide a diverse range of aesthetic and general healthcare services. His management has overseen the company's efforts to sustain its service offerings, including surgical and non-surgical aesthetic treatments, as well as general medical care. Specific achievements or strategic decisions under his direct leadership are not detailed in the provided information, but his role is central to the company's ongoing operations and strategic direction.
Aesthetic Medical International Holdings Group Limited ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate issued by a U.S. bank representing shares in a foreign stock. For PAIYY, as a Level 1 ADR, it allows U.S. investors to trade shares of Aesthetic Medical International Holdings Group Limited (whose home market ticker is PAIY in Shenzhen, CN) on the U.S. OTC market. This mechanism simplifies foreign investment by allowing transactions in U.S. dollars and through U.S. brokers, bypassing direct trading on foreign exchanges.
- Home Market Ticker: The primary stock exchange for Aesthetic Medical International Holdings Group Limited (PAIY) is in Shenzhen, China.
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: PAIY
PAIYY OTC Market Information
PAIYY trades on the OTC Other tier of the OTC Markets Group. This tier is for companies that do not meet the disclosure requirements for OTCQX or OTCQB, or that choose not to provide financial information to the public. Unlike companies listed on major exchanges like NYSE or NASDAQ, which have stringent listing standards regarding market capitalization, share price, and financial reporting, OTC Other companies have minimal or unknown public disclosure. This results in significantly less transparency, higher risk, and often lower liquidity compared to higher OTC tiers or exchange-listed stocks, making comprehensive due diligence more challenging for investors.
- OTC Tier: OTC Other
- Limited or Unknown Public Disclosure: Difficulty in accessing reliable financial and operational information.
- Low Liquidity: Challenges in buying or selling shares quickly without significant price impact.
- Price Volatility: Shares can be subject to extreme price swings due to low trading volume and limited market depth.
- Lack of Regulatory Oversight: Less stringent reporting and compliance requirements compared to major exchanges.
- Potential for Manipulation: Lower transparency and liquidity can make OTC stocks more susceptible to market manipulation.
- Verify the company's official website for any direct financial statements or press releases.
- Search for any regulatory filings in China or Singapore, if available, through local authorities.
- Assess the company's operational footprint and physical assets through independent verification.
- Research management's background and any public statements or interviews.
- Evaluate the competitive landscape and market trends in China and Singapore for aesthetic medicine.
- Consider the company's history of operations and any past financial performance indicators.
- Consult with financial advisors experienced in international and OTC markets.
- Established Founding Year: Founded in 1997, indicating a long operational history.
- Physical Headquarters: Located in Shenzhen, China, suggesting a tangible operational base.
- Employee Count: 1286 employees, indicating a substantial workforce and active operations.
- Specific Service Offerings: Detailed descriptions of surgical, non-surgical, and general healthcare services.
- Geographic Operations: Presence in both China and Singapore, suggesting real-world business activities.
Common Questions About PAIYY (Healthcare)
What does the AI Score mean for PAIYY?
PAIYY holds an AI Score of 51/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. Aesthetic Medical International Holdings Group Limited offers surgical, non-surgical, and general healthcare services across China and Singapore. The company focuses on aesthetic treatments …
What range of services does Aesthetic Medical International Holdings Group Limited provide?
Aesthetic Medical International Holdings Group Limited offers a comprehensive suite of medical services across two primary categories: aesthetic treatments and general healthcare. Within aesthetic treatments, the company provides both surgical options, such as eye surgery, rhinoplasty, breast augmentation, and liposuction, and non-surgical alternatives, including minimally invasive procedures and energy-based treatments like laser, ultrasound, and radiofrequency therapies.
How does Aesthetic Medical International Holdings Group Limited manage its market presence in China and Singapore?
Aesthetic Medical International Holdings Group Limited strategically manages its market presence by operating in both the People's Republic of China and Singapore, leveraging the distinct characteristics of each market. In China, the company taps into a vast and rapidly growing consumer base with increasing disposable incomes and evolving perceptions towards aesthetic medicine.
What are the financial implications of PAIYY's current profitability and market status?
Aesthetic Medical International Holdings Group Limited's current financial profile presents a mixed picture, with a strong gross margin of 46.2% indicating efficient service delivery, yet a negative profit margin of -7.4% suggesting challenges in covering operating expenses and achieving net profitability.
What are the specific risks associated with PAIYY being an OTC-traded ADR?
Investing in PAIYY, as an OTC-traded American Depositary Receipt (ADR), carries several specific risks. Firstly, its "OTC Other" tier classification and "Unknown" disclosure status mean there is very limited public financial information available, making comprehensive due diligence challenging. This lack of transparency can obscure the company's true financial health and operational risks.
What are the key factors to evaluate for PAIYY?
Aesthetic Medical International Holdings Group Limited (PAIYY) holds an AI score of 51/100 (moderate). Not financial advice.
How frequently does PAIYY data refresh on this page?
PAIYY's price was last updated on Jul 24, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven PAIYY's recent stock price performance?
Aesthetic Medical International Holdings Group Limited (PAIYY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Broad portfolio of surgical, non-surgical aesthetic, and general healthcare services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider PAIYY overvalued or undervalued right now?
Aesthetic Medical International Holdings Group Limited (PAIYY) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Market capitalization of $0.00B is noted as a potential data anomaly or indicative of extremely low valuation/liquidity. OTC disclosure status is 'Unknown', limiting financial transparency. CEO tenure years are not provided in source data.